 |
H1N1 flu cases surge in India following monsoon - Jul 26, 2010 According to the Times of India (ToI), health ministry officials are concerned with the growing number of H1N1 flu cases in various parts of the country since the beginning of monsoons. The Press Trust of India (PTI) reported that 38 casualties were recorded during the past week with the states of Maharashtra and Kerala enduring the brunt of the infections. Between July 19 and Monday (July 26), 18 deaths were tallied in Maharashtra, while Kerala reported eight deaths, according to the PTI. The Health Ministry reported that there were a total of 548 new cases counted last week, which is the highest this year, ToI said. So far, the ToI noted that Maharashtra state has reported the highest number of cases this week with 230, followed by 108 cases in Kerala and 86 in Karnataka. Additionally, a handful of cases have also been recorded in Haryana, Gujurat, Uttar Pradesh and Jammu and Kashmir. A health ministry official told the Indo Asian News Service (IANS) that "The moisture due to monsoon is giving a good breeding ground to the virus, precautionary measures, such as washing of hands, covering the nose and avoiding crowded places must be followed." Because of the growing number of cases, health officials should also ramp up efforts to continue to educate the public, encouraging vigilance since the pandemic has not been declared over. So far, ToI reported that the Health Ministry recommended the use of H1N1 flu vaccines to avoid the threat. In other news, Gen-Probe Incorporated, a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that can be used to diagnose human diseases, announced on Monday that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProFAST + assay that is able to detect and differentiate between three common influenza A virus subtypes: seasonal A/H1, seasonal A/H3 and 2009 pandemic H1N1, Medical News Today reported. The assay is not only important for public health, but it is the only FDA-cleared detection test for these viruses that enables physicians to accurately distinguish between influenza A subtypes that have different antiviral susceptibilities. Meanwhile, the latest UN World Health Organization (WHO) update on Friday (July 30) reported over 18,398 deaths worldwide in over 214 countries and overseas territories or communities reporting laboratory-confirmed cases of pandemic influenza H1N1 2009. Generally, overall pandemic and seasonal influenza activity remains low, the WHO reported. However, in the southern hemisphere, where the winter season is in progress, influenza activity is variable. The most active area in Asia is in parts of India as mentioned above. The WHO is close to ending the pandemic, which was declared in June 2009, but continue to monitor the progress through frequent consultations with the WHO Regional Offices and member states and through monitoring of multiple sources of information.
·
Medical News today,
Jul 26, 2010,
http://www.medicalnewstoday.com
·
Press Trust of India,
Jul 27, 2010,
http://ibnlive.in.com
·
Times of India,
Jul 27, 2010,
http://timesofindia.indiatimes.com
·
WHO,
Jul 30, 2010,
http://www.who.int
|